Healthcare Distribution Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

The healthcare distribution market is projected to reach USD 1,118.4 billion by 2030 from USD 755.4 billion in 2019, at a CAGR of 7.5%.

Clear

Description

Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) – Global Forecasts to 2030
Product Overview
Healthcare distribution refers to the entire distribution practices in the healthcare industry for accomplishing the tasks including purchasing medical, laboratory and pharmacy supplies, Customer relationship management (CRM), Enterprise resource planning (ERP) support and Information Management. It incorporates varied activities including medicines wholesaling, distribution and associated services.
Market overview
The healthcare distribution market is projected to reach USD 1,118.4 billion by 2030 from USD 755.4 billion in 2019, at a CAGR of 7.5%. The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry. In addition, emerging markets such as China and India, growth in the biosimilars market, increasing specialty drug dispensing, and increasing uptake of biopharmaceuticals are expected to offer potential growth opportunities to market players in the coming years. However, the increasing pricing pressure on market players is a major factor that is expected to impact market growth in the coming years.
The pharmaceutical product distribution services segment dominated the healthcare distribution market in 2018
On the basis of type, the healthcare distribution market is segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In 2018, the pharmaceutical product distribution services segment accounted for the largest share of the market majorly due to the increasing production of pharmaceutical formulations, rising pharmaceutical R&D expenditure, outsourcing of pharmaceutical manufacturing to Asian countries, and the establishment of new manufacturing facilitates by global pharmaceutical giants in newer geographies.
Retail pharmacies to account for the largest share of the healthcare distribution market, by end user, in 2018
Market Dynamics
The high incidence and large economic burden of chronic diseases are primarily driving the market growth. Favorable Investment in R&D activities and increasing launch of new drugs in the healthcare market is supporting the growth of the distribution market. The technological advancements along with the subsequent growth in track & trace solutions in the healthcare distribution industry are further contributing to the growth of the market. The market is also gaining pace owing to the increasing usage of generics in the healthcare sector. In addition to these, the growing medical devices industry is further boosting the demand in the market.

PAC market to grow at the highest CAGR during the forecast period
North America dominated the healthcare distribution market in 2019. However, the APAC market is estimated to grow at the highest CAGR during the forecast period owing to the growing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing and distribution practices and the rising number of pharmaceutical and biotechnology companies in this region. China and India are the fastest-growing markets in this region majorly due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs.
Key Market Players
The prominent players operating in the healthcare distribution market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).
Healthcare Distribution Market, by Type
• Pharmaceutical Product Distribution Services
o OTC Drugs/Vitamins
o Generic Drugs
o Brand-name/Innovator Drugs
• Biopharmaceutical Product Distribution Services
o Monoclonal Antibodies
o Vaccines
o Recombinant Proteins
o Blood and Blood Products
o Other Products (cellular & gene therapy products, stem cell products, and tissue & tissue products)
• Medical Device Distribution Services
Healthcare Distribution Market, by End User
• Retail Pharmacies
• Hospital Pharmacies
• Other End Users (clinical laboratories, physician offices, home care settings, online pharmacies, and long-term care facilities)

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Healthcare Distribution Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Healthcare Distribution Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Healthcare Distribution Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Healthcare Distribution Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Pharmaceutical Product Distribution Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Biopharmaceutical Product Distribution Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Medical Device Distribution Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End User: Market Share (2020-2030F)
12.3.1. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Hospital Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Other, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13 Company Profile
13.1. McKesson Corporation (US)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. AmerisourceBergen Corporation (US)
13.3. Cardinal Health, Inc. (US)
13.4. Owens & Minor, Inc. (US)
13.5. Morris and Dickson Co., LLC (US)
13.6. KeySource Medical, Inc. (US)
13.7. Rochester Drug Cooperative, Inc. (US)
13.8. Henry Schein Inc. (US)
13.9. Smith Drug Company (US)
13.10. FFF Enterprises (US)
13.11. Patterson Companies Inc. (US)
13.12. Other Prominent Players

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.